Suppr超能文献

抗菌药物——第二部分。氨基糖苷类:链霉素、卡那霉素、庆大霉素、妥布霉素、阿米卡星、新霉素。

Antimicrobial agents--Part II. The aminoglycosides: streptomycin, kanamycin, gentamicin, tobramycin, amikacin, neomycin.

作者信息

Brewer N S

出版信息

Mayo Clin Proc. 1977 Nov;52(11):675-9.

PMID:336988
Abstract

Aminoglycoside antibiotics are poorly absorbed from the gastrointestinal tract, do not penetrate well into the cerebrospinal fluid, are minimally bound to plasma proteins, and are rapidly excreted by the normal kidney. Neomycin is limited by its toxicity to irrigating and topical preparations or to oral medication for surgical bowel preparations or hepatic coma. Streptomycin has only a few specific indications, because newer agents are available that have broader spectrums of activity. Kanamycin is indicated in serious gram-negative infections in which Pseudomonas aeruginosa is not a likely causative agent. Gentamicin, tobramycin, and amikacin are effective against a broad spectrum of gram-negative organisms including P. aeruginosa. In general, both gentamicin and tobramycin are more active in vitro than amikacin on a weight basis; however, higher serum levels are achievable with amikacin than with the two others. Amikacin is probably the aminoglycoside of first choice when gentamicin resistance is strongly suspected.

摘要

氨基糖苷类抗生素从胃肠道吸收差,不易透过血脑屏障,与血浆蛋白结合少,且经正常肾脏迅速排泄。新霉素因毒性限制,仅用于冲洗和局部制剂,或用于外科肠道准备或肝昏迷的口服给药。链霉素只有少数特定适应证,因为有了活性谱更广的新型药物。卡那霉素适用于不太可能由铜绿假单胞菌引起的严重革兰氏阴性菌感染。庆大霉素、妥布霉素和阿米卡星对包括铜绿假单胞菌在内的多种革兰氏阴性菌有效。一般来说,按重量计算,庆大霉素和妥布霉素在体外的活性均高于阿米卡星;然而,阿米卡星可达到比其他两者更高的血清水平。当强烈怀疑对庆大霉素耐药时,阿米卡星可能是首选的氨基糖苷类药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验